1. Home
  2. QURE vs WRLD Comparison

QURE vs WRLD Comparison

Compare QURE & WRLD Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.

  • Machine Learning Prediction
  • ML Decision
  • QURE
  • WRLD
  • Stock Information
  • Founded
  • QURE 1998
  • WRLD 1962
  • Country
  • QURE Netherlands
  • WRLD United States
  • Employees
  • QURE N/A
  • WRLD N/A
  • Industry
  • QURE Biotechnology: Pharmaceutical Preparations
  • WRLD Finance: Consumer Services
  • Sector
  • QURE Health Care
  • WRLD Finance
  • Exchange
  • QURE Nasdaq
  • WRLD Nasdaq
  • Market Cap
  • QURE 725.4M
  • WRLD 727.3M
  • IPO Year
  • QURE 2007
  • WRLD 1991
  • Fundamental
  • Price
  • QURE $17.27
  • WRLD $162.99
  • Analyst Decision
  • QURE Strong Buy
  • WRLD
  • Analyst Count
  • QURE 10
  • WRLD 0
  • Target Price
  • QURE $37.20
  • WRLD N/A
  • AVG Volume (30 Days)
  • QURE 1.4M
  • WRLD 35.5K
  • Earning Date
  • QURE 07-31-2025
  • WRLD 07-25-2025
  • Dividend Yield
  • QURE N/A
  • WRLD N/A
  • EPS Growth
  • QURE N/A
  • WRLD 23.58
  • EPS
  • QURE N/A
  • WRLD 16.30
  • Revenue
  • QURE $20,201,000.00
  • WRLD $564,781,378.00
  • Revenue This Year
  • QURE $27.16
  • WRLD N/A
  • Revenue Next Year
  • QURE $248.21
  • WRLD N/A
  • P/E Ratio
  • QURE N/A
  • WRLD $9.62
  • Revenue Growth
  • QURE 6.30
  • WRLD N/A
  • 52 Week Low
  • QURE $3.73
  • WRLD $101.85
  • 52 Week High
  • QURE $19.18
  • WRLD $161.63
  • Technical
  • Relative Strength Index (RSI)
  • QURE 67.53
  • WRLD 72.02
  • Support Level
  • QURE $14.75
  • WRLD $154.41
  • Resistance Level
  • QURE $15.50
  • WRLD $156.21
  • Average True Range (ATR)
  • QURE 1.07
  • WRLD 4.54
  • MACD
  • QURE 0.16
  • WRLD 0.58
  • Stochastic Oscillator
  • QURE 93.40
  • WRLD 100.00

About QURE uniQure N.V.

uniQure NV is a gene therapy company. It develops treatments and platforms for patients suffering from genetic and other devastating diseases. Its products and services are focused on hemophilia, Huntington's disease, and cardiovascular diseases. The company is focused on the development of the pipeline of gene therapies with the collaboration of Bristol Myers Squibb for cardiovascular diseases.

About WRLD World Acceptance Corporation

World Acceptance Corp operates a small-loan consumer finance business. The company offers short-term small installment loans, medium-term larger installment loans, related credit insurance and ancillary products and services to individuals. It also offers income tax return preparation services to its loan customers and other individuals.

Share on Social Networks: